References
- von Schweinitz D. Hepatoblastoma: recent developments in research and treatment. In Seminars in pediatric surgery, vol. 21, no. 1, p. 21-30. WB Saunders, 2012.
- Birch JM. Epidemiology of pediatric liver tumors, In Pediatric Liver Tumors. Berlin, Heidelberg: Springer; 2011. p. 15-26.
- Perilongo G, Malogolowkin M, Feusner J. Hepatoblastoma clinical research: lessons learned and future challenges. Pediatr Blood Cancer. 2012;59:818–821.
- Lieber J, Kirchner B, Eicher C, et al. Inhibition of Bcl‐2 and Bcl‐X enhances chemotherapy sensitivity in hepatoblastoma cells. Pediatr Blood Cancer. 2010;55:1089–1095.
- Marin J, Romero M, Martinez-Becerra P, et al. Overview of the molecular bases of resistance to chemotherapy in liver and gastrointestinal tumours. CMM. 2009;9(9):1108–1129.
- Engels BM, Hutvagner G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene. 2006;25(46):6163.
- Seike M, Goto A, Okano T, et al. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci. 2009;106(29):12085–12090.
- Samuels-Lev Y, O'Connor DJ, Bergamaschi D, et al. ASPP proteins specifically stimulate the apoptotic function of p53. Mol cell. 2001;8(4):781–794.
- Lossos IS, Natkunam Y, Levy R, et al. Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: correlation with clinical outcome. Leuk lymphoma. 2002;43:2309–2317.
- Papagiannakopoulos T, Shapiro A, Kosik KS. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res. 2008;68(19):8164–8172.
- Roebuck DJ, Aronson D, Clapuyt P, et al. 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol. 2007;37(2):123–132.
- Anaya J. OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs. PeerJ Comput Sci. 2016;2:e67.
- Cui Y, Lu P, Song G, et al. Involvement of PI3K/Akt, ERK and p38 signaling pathways in emodin-mediated extrinsic and intrinsic human hepatoblastoma cell apoptosis. Food Chem Toxicol. 2016;92:26–37.
- Doberstein K, Steinmeyer N, Hartmetz A-K, et al. MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patients. Neoplasia. 2013;15(2):218.
- Doberstein K, Bretz NP, Schirmer U, et al. miR-21-3p is a positive regulator of L1CAM in several human carcinomas. Cancer Lett. 2014;354(2):455–466.
- Zhang FZ, Ho DH-H, Wong RH-F. Triptolide, a HSP90 middle domain inhibitor, induces apoptosis in triple manner. Oncotarget. 2018;9(32):22301.
- Pulito C, Mori F, Sacconi A, et al. Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities. Cell Discov. 2017;3(1):17022.
- Liu W, Xia P, Feng J, et al. MicroRNA-132 upregulation promotes matrix degradation in intervertebral disc degeneration. Exp Cell Res. 2017;359(1):39–49.
- He X, Chang Y, Meng F, et al. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene. 2012;31(28):3357.
- Wang P, Zou F, Zhang X, et al. microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res. 2009;69(20):8157–8165.
- Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005;65(14):6029–6033.
- Liu W, Chen S, Liu B. Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study. Pediatr Surg Int. 2016;32(11):1059–1065.
- Gyugos M, Lendvai G, Kenessey I, et al. MicroRNA expression might predict prognosis of epithelial hepatoblastoma. Virchows Arch. 2014;464(4):419–427.
- Liu M-F, Jiang S, Lu Z, et al. Physiological and pathological functions of mammalian microRNAs; 2010; 427–446.
- Koff JL, Ramachandiran S, Bernal-Mizrachi L. A time to kill: targeting apoptosis in cancer. IJMS. 2015;16(2):2942–2955.
- Yan LX, Wu QN, Zhang Y, et al. Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth. Breast cancer Res. 2011;13(1):R2.
- Buscaglia LEB, Li Y. Apoptosis and the target genes of microRNA-21. Chinese J Cancer. 2011;30(6):371.
- Wang G, Lemos JR, Iadecola C. Herbal alkaloid tetrandrine: from an ion channel blocker to inhibitor of tumor proliferation. Trends Pharmacol Sci. 2004;25(3):120–123.
- Tseng S-H, Wang C-H, Lin S-M, et al. Activation of c-Jun N-terminal kinase 1 and caspase 3 in the tamoxifen-induced apoptosis of rat glioma cells. J Cancer Res Clin Oncol. 2004;130(5):285–293.
- Manke IA, Nguyen A, Lim D, et al. MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol cell. 2005;17(1):37–48.